Analysts Set Stryker Co. (NYSE:SYK) Price Target at $421.90

Shares of Stryker Co. (NYSE:SYK) have been assigned an average rating of “Moderate Buy” from the twenty ratings firms that are covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and sixteen have issued a buy recommendation on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $421.90.

Several brokerages recently issued reports on SYK. Needham & Company LLC reiterated a “buy” rating and set a $442.00 price target on shares of Stryker in a research report on Wednesday, January 29th. JMP Securities reissued a “market perform” rating on shares of Stryker in a research report on Tuesday, February 18th. Citigroup reaffirmed a “buy” rating and issued a $450.00 price target on shares of Stryker in a research note on Wednesday, February 26th. Wells Fargo & Company raised their price objective on Stryker from $427.00 to $435.00 and gave the company an “overweight” rating in a research report on Wednesday, January 29th. Finally, Stifel Nicolaus upped their target price on shares of Stryker from $400.00 to $440.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th.

Insider Activity

In other news, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now directly owns 3,642,075 shares of the company’s stock, valued at $1,428,567,498. This represents a 5.24 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Allan C. Golston sold 2,458 shares of the company’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the sale, the director now owns 14,895 shares of the company’s stock, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Institutional Investors Weigh In On Stryker

Hedge funds and other institutional investors have recently made changes to their positions in the business. Kohmann Bosshard Financial Services LLC purchased a new stake in Stryker during the fourth quarter valued at approximately $25,000. Capital A Wealth Management LLC bought a new stake in shares of Stryker during the 4th quarter valued at $26,000. Dunhill Financial LLC increased its stake in shares of Stryker by 94.9% in the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Rakuten Securities Inc. raised its holdings in Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company’s stock worth $28,000 after purchasing an additional 68 shares during the period. Finally, Centricity Wealth Management LLC purchased a new position in Stryker during the fourth quarter valued at $30,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Stryker Stock Up 0.7 %

Shares of NYSE:SYK opened at $376.13 on Friday. Stryker has a 1 year low of $314.93 and a 1 year high of $406.19. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The stock’s 50-day moving average is $383.71 and its 200 day moving average is $373.82. The company has a market cap of $143.52 billion, a PE ratio of 48.47, a P/E/G ratio of 2.93 and a beta of 0.95.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the prior year, the firm earned $3.46 earnings per share. Sell-side analysts anticipate that Stryker will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.89%. The ex-dividend date is Monday, March 31st. Stryker’s dividend payout ratio is currently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.